Your browser doesn't support javascript.
loading
First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational Study.
Dieras, Veronique; Pop, Simona; Berger, Frederique; Dujaric, Marie-Eglantine; Beuzeboc, Philippe; Escalup, Laurence; Bidard, François Clement; Cottu, Paul Henri; LE Tourneau, Christophe; Piperno-Neumann, Sophie; Laurence, Valerie; Robain, Mathieu; Asselain, Bernard; Pierga, Jean-Yves.
Afiliación
  • Dieras V; Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France veronique.dieras@curie.fr.
  • Pop S; Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France.
  • Berger F; Biostatistics Unit, Curie Institute, PSL Research University, Paris, France.
  • Dujaric ME; INSERM U900, Curie Institute, PSL Research University, Paris, France.
  • Beuzeboc P; Biostatistics Unit, Curie Institute, PSL Research University, Paris, France.
  • Escalup L; Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France.
  • Bidard FC; Pharmacy Department, Curie Institute, PSL Research University, Paris, France.
  • Cottu PH; Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France.
  • LE Tourneau C; INSERM U900, Curie Institute, PSL Research University, Paris, France.
  • Piperno-Neumann S; Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France.
  • Laurence V; Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France.
  • Robain M; Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France.
  • Asselain B; Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France.
  • Pierga JY; Biostatistics Unit, Curie Institute, PSL Research University, Paris, France.
Anticancer Res ; 37(3): 1403-1407, 2017 03.
Article en En | MEDLINE | ID: mdl-28314310
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Paclitaxel / Receptor ErbB-2 / Neoplasias de la Mama Triple Negativas / Bevacizumab Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Anticancer Res Año: 2017 Tipo del documento: Article País de afiliación: Francia
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Paclitaxel / Receptor ErbB-2 / Neoplasias de la Mama Triple Negativas / Bevacizumab Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Anticancer Res Año: 2017 Tipo del documento: Article País de afiliación: Francia